Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Rotavirus
Study results from H. Melliez and colleagues update understanding of rotavirus
March 26th, 2008
In this recent report published in the journal Vaccine, researchers in Tourcoing, France conducted a study "To assess the effectiveness and cost-effectiveness of routine childhood vaccination by new vaccines against rotavirus in France. We constructed a Markov decision tree to compare two alternatives: ''no vaccination'' and ''vaccination''." "A hypothetical birth cohort of 750,000 children was followed until 3 years of age. First, the disease burden without vaccine was estimated using data from French databases and medical literature. Incidence rates in unvaccinated children were modelled as a function of age and seasons. Next, using data from the medical....
Source: Vaccine Weekly (2008-03-26)
|
